To quote from Wikipedia, Segal’s Law is an adage that states: “A man with a watch knows what time it is. A man with two watches is never sure.” How is this relevant to diabetes? Well, for the last fortnight I’ve been wearing three CGMs. It’s been quite enlightening. The three systems I’ve been using have been: …
Over the years I’ve spent some time living with multiple CGM systems: Dexcom G4 and G5 Medtronic Guardian2/Enlite (640G pump) FreeStyle Libre FreeStyle Libre with Spike/xDrip+ Incidentally for the purposes of this technical discussion, the Libre is a Continuous Glucose Monitor. Any lack of alarms/etc does not change this, even if “Flash” monitoring doesn’t have …
In October 2018 I was privileged to be an invited keynote speaker at ADATS 2018. The Australian Diabetes Advancements and Technologies Summit is a one-day event for healthcare professionals. That is, doctors, nurses, etc. People who “only” live with diabetes don’t normally get a look-in. This article is a summary of my presentation. I’ve put most …
It can be tricky to gauge how many people are managing their diabetes using DIY closed-loop pump systems, as there’s no mandatory reporting. The tools are out there, and people are free to start looping by themselves. We recently saw the results of a UK-based survey, which at the beginning of September showed at least …
Australian DIY APS looping survey, September 2018 Read More »
NOTE: this article was superceded in November 2018. Please check out the updated article! It’s time for another update as to the insulin pumps on the Australian scene! There have been a few developments lately, with new pumps introduced along with updates to the Health Department’s Prostheses List. This article is our latest summary of …
Well as I expected, lots has been happening in the diabetes tech world while I’ve been away working on the African photographic expedition. So this post is a little bit of a catch-up. Ryzodeg At the start of August the Australian PBS was updated to include Novo’s Ryzodeg insulin. Although Novo’s long-acting Tresiba is not …